JPWO2022261395A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022261395A5 JPWO2022261395A5 JP2023575819A JP2023575819A JPWO2022261395A5 JP WO2022261395 A5 JPWO2022261395 A5 JP WO2022261395A5 JP 2023575819 A JP2023575819 A JP 2023575819A JP 2023575819 A JP2023575819 A JP 2023575819A JP WO2022261395 A5 JPWO2022261395 A5 JP WO2022261395A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- set forth
- sequence set
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163209915P | 2021-06-11 | 2021-06-11 | |
| US63/209,915 | 2021-06-11 | ||
| PCT/US2022/032944 WO2022261395A1 (en) | 2021-06-11 | 2022-06-10 | Anti-upar antibodies and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024522371A JP2024522371A (ja) | 2024-06-18 |
| JP2024522371A5 JP2024522371A5 (https=) | 2025-06-18 |
| JPWO2022261395A5 true JPWO2022261395A5 (https=) | 2025-06-18 |
Family
ID=84425501
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023575819A Pending JP2024522371A (ja) | 2021-06-11 | 2022-06-10 | 抗ｕＰＡＲ抗体及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240254253A1 (https=) |
| EP (1) | EP4352106A4 (https=) |
| JP (1) | JP2024522371A (https=) |
| CN (1) | CN117769569A (https=) |
| AU (1) | AU2022289491A1 (https=) |
| CA (1) | CA3221903A1 (https=) |
| WO (1) | WO2022261395A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025006714A1 (en) * | 2023-06-29 | 2025-01-02 | Cold Spring Harbor Laboratory | Anti-upar car t cells and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200813091A (en) * | 2006-04-10 | 2008-03-16 | Amgen Fremont Inc | Targeted binding agents directed to uPAR and uses thereof |
| WO2013020898A1 (en) * | 2011-08-05 | 2013-02-14 | Ifom Fondazione Istituto Firc Di Oncologia Molecolare | Constitutively active upar variants and their use for the generation and isolation of inhibitory antibodies |
| WO2019113248A1 (en) * | 2017-12-07 | 2019-06-13 | The Regents Of The University Of California | Anti-upar antibody-drug conjugates and methods of use thereof |
| SG11202106765XA (en) * | 2018-12-27 | 2021-07-29 | Gigagen Inc | Anti-pd-1 binding proteins and methods of use thereof |
| WO2020160518A1 (en) * | 2019-02-01 | 2020-08-06 | Memorial Sloan Kettering Cancer Center | Senolytic car-t cells targeting upar, a cell surface and secreted senescence biomarker |
| CN113874083A (zh) * | 2019-03-01 | 2021-12-31 | 梅里麦克制药股份有限公司 | 抗-tnfr2抗体及其用途 |
-
2022
- 2022-06-10 EP EP22821080.3A patent/EP4352106A4/en active Pending
- 2022-06-10 CN CN202280054177.2A patent/CN117769569A/zh active Pending
- 2022-06-10 JP JP2023575819A patent/JP2024522371A/ja active Pending
- 2022-06-10 AU AU2022289491A patent/AU2022289491A1/en active Pending
- 2022-06-10 CA CA3221903A patent/CA3221903A1/en active Pending
- 2022-06-10 WO PCT/US2022/032944 patent/WO2022261395A1/en not_active Ceased
-
2023
- 2023-12-11 US US18/535,395 patent/US20240254253A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021514664A5 (https=) | ||
| TWI777056B (zh) | 結合至ssea4的單株抗體及其用途 | |
| JP2006502698A5 (https=) | ||
| CN115819585B (zh) | 一种抗lag-3的单克隆抗体、其抗原结合片段及其应用 | |
| JP2010504755A5 (https=) | ||
| JP2021511811A5 (https=) | ||
| JP2023553758A (ja) | 抗ＳＩＲＰα抗体およびその適用 | |
| JPWO2019175222A5 (https=) | ||
| JP5371780B2 (ja) | Ｃｘｃｒ３に対するヒト化抗体 | |
| EP4023673A1 (en) | Humanized monoclonal antibody targeting bcma and having human monkey cross-reactivity | |
| JP7755062B2 (ja) | 新規抗ｌ１ｃａｍ抗体 | |
| JP2020533965A5 (https=) | ||
| WO2022157773A2 (en) | Dual binding antibodies, methods of producing dual binding antibodies, and uses thereof | |
| CN114591434A (zh) | 抗Siglec15抗体及其制备方法和用途 | |
| JP2023538117A (ja) | 神経免疫疾患のためのｃｄ３／ｃｄ２５抗体 | |
| JP2020531003A5 (https=) | ||
| CN105131117B (zh) | 靶向HER2的人源化改造的可内化单链抗体P1h2及应用 | |
| JPWO2021138474A5 (https=) | ||
| JPWO2022261405A5 (https=) | ||
| JPWO2022261395A5 (https=) | ||
| CA3221895A1 (en) | Anti-upar antibodies and uses thereof | |
| JPWO2023098888A5 (https=) | ||
| CN105131116B (zh) | 靶向HER2的人源化改造的可内化单链抗体P1h3及制备方法和应用 | |
| CA3221903A1 (en) | Anti-upar antibodies and uses thereof | |
| CN107840886B (zh) | Gm-csf抗体及其用途 |